127 related articles for article (PubMed ID: 21980808)
21. Steroid Screening Tools Differentiating Nonclassical Congenital Adrenal Hyperplasia and Polycystic Ovary Syndrome.
Maffazioli GDN; Bachega TASS; Hayashida SAY; Gomes LG; Valassi HPL; Marcondes JAM; Mendonca BB; Baracat EC; Maciel GAR
J Clin Endocrinol Metab; 2020 Aug; 105(8):. PubMed ID: 32530459
[TBL] [Abstract][Full Text] [Related]
22. Serum and urinary steroids in girls with precocious pubarche and/or hirsutism due to mild 3-beta-hydroxysteroid dehydrogenase deficiency.
Sólyom J; Halász Z; Hosszú E; Gláz E; Vihko R; Orava M; Homoki J; Wudy SA; Teller WM
Horm Res; 1995; 44(3):133-41. PubMed ID: 7590644
[TBL] [Abstract][Full Text] [Related]
23. Basal levels of 17-hydroxyprogesterone can distinguish children with isolated precocious pubarche.
Grandone A; Marzuillo P; Luongo C; Toraldo R; Mariani M; Miraglia Del Giudice E; Perrone L
Pediatr Res; 2018 Oct; 84(4):533-536. PubMed ID: 29976972
[TBL] [Abstract][Full Text] [Related]
24. Monitoring congenital adrenal hyperplasia using blood spot 17-hydroxyprogesterone assay.
Santos CM; Abad LR; Cua SC; Domingo CF
Southeast Asian J Trop Med Public Health; 2003; 34 Suppl 3():174-8. PubMed ID: 15906729
[TBL] [Abstract][Full Text] [Related]
25. The value of low dose (1 microg) ACTH stimulation test in the investigation of non-classic adrenal hyperplasia due to 11beta-hydroxylase deficiency.
Unlühizarci K; Keleştimur F; Güven M; Bayram F; Colak R
Exp Clin Endocrinol Diabetes; 2002 Nov; 110(8):381-5. PubMed ID: 12518247
[TBL] [Abstract][Full Text] [Related]
26. Congenital adrenal hyperplasia: family screening using 17-hydroxyprogesterone (17-OHP) response to adrenocorticotropin (ACTH).
Soliman AT; Omar M; Al Ali M; Rizk MM; Nasr I; AbolMagd M
J Trop Pediatr; 2006 Apr; 52(2):147-8. PubMed ID: 16258004
[No Abstract] [Full Text] [Related]
27. Prevalence of nonclassical steroid 21-hydroxylase deficiency based on a morning salivary 17-hydroxyprogesterone screening test: a small sample study.
Zerah M; Ueshiba H; Wood E; Speiser PW; Crawford C; McDonald T; Pareira J; Gruen D; New MI
J Clin Endocrinol Metab; 1990 Jun; 70(6):1662-7. PubMed ID: 2347899
[TBL] [Abstract][Full Text] [Related]
28. A prospective study of the prevalence of nonclassical congenital adrenal hyperplasia among women presenting with hyperandrogenic symptoms and signs.
Escobar-Morreale HF; Sanchón R; San Millán JL
J Clin Endocrinol Metab; 2008 Feb; 93(2):527-33. PubMed ID: 18000084
[TBL] [Abstract][Full Text] [Related]
29. Changes in steroid pattern following acute and chronic adrenocorticotropin administration in premature adrenarche.
Toscano V; Balducci R; Adamo MV; Mangiantini A; Cives C; Boscherini B
J Steroid Biochem; 1989 Feb; 32(2):321-6. PubMed ID: 2537914
[TBL] [Abstract][Full Text] [Related]
30. [Salivary 17-hydroxyprogesterone concentration in monitoring of the treatment of congenital adrenal hyperplasia].
Arisaka O; Shimura N; Nakayama Y; Arisaka M; Yabuta K
Dtsch Med Wochenschr; 1988 Dec; 113(49):1913-5. PubMed ID: 3197614
[TBL] [Abstract][Full Text] [Related]
31. [Premature pubarche is not always an innocent phenomenon].
Backes M; Zwaveling-Soonawala N; Kamp GA
Ned Tijdschr Geneeskd; 2012; 156(43):A5147. PubMed ID: 23095481
[TBL] [Abstract][Full Text] [Related]
32. Genetic defects of steroidogenesis in premature pubarche.
Temeck JW; Pang SY; Nelson C; New MI
J Clin Endocrinol Metab; 1987 Mar; 64(3):609-17. PubMed ID: 3029158
[TBL] [Abstract][Full Text] [Related]
33. Variable ACTH-stimulated 17-hydroxyprogesterone values in 21-hydroxylase deficiency carriers are not related to the different CYP21 gene mutations.
Bachega TA; Brenlha EM; Billerbeck AE; Marcondes JA; Madureira G; Arnhold IJ; Mendonca BB
J Clin Endocrinol Metab; 2002 Feb; 87(2):786-90. PubMed ID: 11836321
[TBL] [Abstract][Full Text] [Related]
34. Identification of nonclassical 21-hydroxylase deficiency in girls with precocious pubarche.
Leite MV; Mendonça BB; Arnhold IJ; Estefan V; Nunes C; Nicolau W; Bloise W
J Endocrinol Invest; 1991 Jan; 14(1):11-5. PubMed ID: 1646249
[TBL] [Abstract][Full Text] [Related]
35. Anthropometric and endocrine features in girls with isolated premature pubarche or non-classical congenital adrenal hyperplasia.
Accetta SG; Di Domênico K; Ritter CG; Ritter AT; Capp E; Spritzer PM
J Pediatr Endocrinol Metab; 2004 May; 17(5):767-73. PubMed ID: 15237712
[TBL] [Abstract][Full Text] [Related]
36. Raised 17-hydroxyprogesterone levels in congenital adrenal hyperplasia.
Iqbal S; Khan AH
J Coll Physicians Surg Pak; 2013 May; 23(5):373-4. PubMed ID: 23673184
[TBL] [Abstract][Full Text] [Related]
37. ACTH stimulation tests and plasma dehydroepiandrosterone sulfate levels in women with hirsutism.
Siegel SF; Finegold DN; Lanes R; Lee PA
N Engl J Med; 1990 Sep; 323(13):849-54. PubMed ID: 2168515
[TBL] [Abstract][Full Text] [Related]
38. 17-Hydroxyprogesterone response to ACTH in bilateral and monolateral adrenal incidentalomas.
Bernini GP; Brogi G; Vivaldi MS; Argenio GF; Sgrò M; Moretti A; Salvetti A
J Endocrinol Invest; 1996 Dec; 19(11):745-52. PubMed ID: 9061508
[TBL] [Abstract][Full Text] [Related]
39. Congenital adrenal hyperplasia: neonatal mass screening compared with clinical diagnosis only in the Emilia-Romagna region of Italy, 1980-1995.
Balsamo A; Cacciari E; Piazzi S; Cassio A; Bozza D; Pirazzoli P; Zappulla F
Pediatrics; 1996 Sep; 98(3 Pt 1):362-7. PubMed ID: 8784357
[TBL] [Abstract][Full Text] [Related]
40. [About a case of congenital hypothyroidism].
d'Almeida M; Georges A; Bordenave L; Corcuff JB
Ann Biol Clin (Paris); 2007; 65(5):539-43. PubMed ID: 17913673
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
